Piramal Enterprises - M&A Summary and Business Overview

Healthcare ServicesCompany

Piramal Enterprises M&A Summary

Piramal Enterprises has acquired 12 companies, including 1 in the last 5 years. A total of 4 acquisitions came from private equity firms. It has also divested 3 assets.

Piramal Enterprises’ largest acquisition to date was in 2012, when it acquired Decision Resources for $635M. It’s largest disclosed sale occurred in 2010, when it sold Piramal Healthcare Generic Drugs to Abbott Laboratories for $3.7B. Piramal Enterprises has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (50%) and medical products (17%).

Piramal Enterprises Business Overview

Where is Piramal Enterprises headquartered?

Piramal Enterprises is headquartered in Mumbai, India.

What is Piramal Enterprises’ revenue?

Piramal Enterprises disclosed revenue of 81,058M INR for 2024 and 82,169M INR for 2023.

How many employees does Piramal Enterprises have?

Piramal Enterprises has 3,000 employees.

What sector is Piramal Enterprises in?

Piramal Enterprises is a healthcare services company.

When was Piramal Enterprises founded?

Piramal Enterprises was founded in 1947.

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity12
    • M&A Sell Activity3
  • Total Sectors Invested 5
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 9
  • M&A Advisors 2

Piramal Enterprises

Piramal Enterprises Ltd.

Piramal Ananta, Agastya Corporate Park 109 A, 109A/1 to 109/21A, 111 and 110, 110/1 to 110/13 Opposite Fire Brigade, Kamani Junction LBS Marg, Kurla (West),
Mumbai, 400070
India,
+91 22 3802 3000
www.piramal.com

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, India.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 11 - 1 - - - 12
vol $892M $892M
Sell (0.2/yr) # 2 1 - - - - 3
vol $3.7B $950M $4.7B
  15

Most Recent M&A

Company Date Value Type
Hemmo Pharmaceutical Pvt Ltd. 2021-03-31 - Add-on Acquisition
Mumbai, India · www.hemmopharma.com
Decision Resources Group (DRG) 2020-01-17 950M USD Divestiture
Burlington, Massachusetts · www.decisionresourcesgroup.com
Mallinckrodt plc - Intrathecal Therapy Business 2017-01-30 171M USD Divestiture
Dublin, Ireland
Ash Stevens, Inc. 2016-08-16 43M USD Add-on Acquisition
Riverview, Michigan · www.ashstevens.com
Piramal Clinical Research 2015-04-01 - Divestiture
, India
Coldstream Laboratories, Inc. 2015-01-16 31M USD Add-on Acquisition
Lexington, Kentucky · www.coldstreamlabs.com
Shriram Capital Ltd 2014-12-15 - Stake Purchase
Chennai, India · www.shriramcapital.com
Valeant Pharmaceuticals Caladryl 2013-11-01 - Divestiture
, India
Shriram Finance Ltd. 2013-05-10 - Stake Purchase
Mumbai, India · www.shriramfinance.in
Decision Resources LLC 2012-05-16 635M USD Add-on Acquisition
Burlington, Massachusetts · www.decisionresources.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Piramal Healthcare (Canada) Ltd.    - BST-CarGel 2016-01-12 1
Aurora, Ontario , United States

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 6 (50%) 257M (29%) 2 (67%) 3.7B (80%)
Financial Services 2 (17%) - - -
Medical Products 2 (17%) - - -
Consumer Products 1 (8%) - - -
Healthcare Services 1 (8%) 635M (71%) - -
Information Technology - - 1 (33%) 950M (20%)
Total 12 $892M 3 $4.7B

By Geo

State/Country Buy Value Sell Value
India 5 - 2 3.7B
United States 5 713M 1 950M
  Massachusetts 1 635M 1 950M
  New York 1 - - -
  Michigan 1 43M - -
  Kentucky 1 31M - -
  Idaho 1 4M - -
Germany 1 9M - -
Ireland 1 171M - -
Domestic 5 (42%) - 2 (67%) 3.7B (80%)
Cross-border 7 (58%) 892M (100%) 1 (33%) 950M (20%)
Total 12 $892M 3 $4.7B

Top M&A Advisors

Legal Deals
Covington & Burling
1
Economic Laws Practice
1

Deal Values

buy # Total
$100M to $1B 2 $806M
< $100M 4 $86M
TOTAL $892M
Largest Decision Resources LLC
$635M (2012-05-16)
sell # Total
> $1B 1 $3.7B
$100M to $1B 1 $950M
TOTAL $4.7B
Largest Piramal Healthcare Generic Drugs
$3.7B (2010-05-26)

M&A Connections

Deals
Acquired from
Investor(s)
33%
4 (33%)
Strategic(s)
33%
4 (33%)
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 208,107
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Piramal Enterprises

Healthcare Services Companies , India Companies